Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial
Launched by TRI-SERVICE GENERAL HOSPITAL · Jan 31, 2014
Trial Information
Current as of June 15, 2025
Completed
Keywords
ClinConnect Summary
Study medication and dosage:
For this study, the investigators used herbal granules prepared according to the formula of R-S-Y-R-T. The investigators purchased the study products from a manufacturer with a Good Manufacturing Practice (Si Wu Tang) certification in Taiwan. This was a concentrated decoction made by water extraction in 1:13 ratio from single batched roots of the 14 plants in proportions: Radix Paeoniae alba (Bai Sau) (90 g), Radix Angelicae sinensis (Dang Guay) (30 g), Pericarpium Citri Reticulatae (Chenpi) (30 g), Radix Astragali (Huangqi) (30 g), Cortex Cinnamomi (Rougui) (3...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • More than 18 years or older
- • With maintenance HD for at least 3 months
- Exclusion Criteria:
- • Malignancy
- • Acute infection
- • Gastrointestinal bleeding
- • Pregnancy
- • Inability to comply with the requirements of study
About Tri Service General Hospital
The Tri-Service General Hospital (TSGH) is a leading medical institution in Taiwan, dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent military hospital, TSGH integrates cutting-edge medical practices with rigorous scientific inquiry, fostering a collaborative environment for healthcare professionals and researchers. The hospital is committed to enhancing treatment outcomes and improving public health by conducting a diverse range of clinical trials across various medical specialties, ensuring adherence to the highest ethical standards and regulatory guidelines. Through its research initiatives, TSGH aims to contribute significantly to the global medical community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials